Order Article Reprints

Nakypova S, Smolobochkin A, Rizbayeva T, Turmanov R, Gazizov A, Akylbekov N, Zhapparbergenov R, Narmanova R, Ibadullayeva S, Zalaltdinova A, et al. Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations. Pharmaceuticals. 2025; 18(7):1056. https://doi.org/10.3390/ph18071056

Nakypova, Saltanat, Andrey Smolobochkin, Tanzilya Rizbayeva, Rakhymzhan Turmanov, Almir Gazizov, Nurgali Akylbekov, Rakhmetulla Zhapparbergenov, Roza Narmanova, Saltanat Ibadullayeva, Alena Zalaltdinova, and et al. 2025. "Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations" Pharmaceuticals 18, no. 7: 1056. https://doi.org/10.3390/ph18071056

Nakypova, S., Smolobochkin, A., Rizbayeva, T., Turmanov, R., Gazizov, A., Akylbekov, N., Zhapparbergenov, R., Narmanova, R., Ibadullayeva, S., Zalaltdinova, A., Syzdykbayev, M., Voronina, J., Lyubina, A., Voloshina, A., Klimanova, E., Sashenkova, T., Mishchenko, D., & Burilov, A. (2025). Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations. Pharmaceuticals, 18(7), 1056. https://doi.org/10.3390/ph18071056